[{"AccountsPayableCurrent_0_Q2_USD":5020000.0,"ProfitLoss_2_Q2_USD":-28308000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":60000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1336000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":7559000.0,"PaymentsOfDebtRestructuringCosts_2_Q2_USD":1389000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":10000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":16000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":18000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":3000.0,"OtherLiabilitiesCurrent_0_Q2_USD":200000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":33034000.0,"OtherAssetsNoncurrent_0_Q2_USD":5901000.0,"OperatingLeasePayments_2_Q2_USD":2830000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":14893000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1637000.0,"OperatingLeaseLiability_0_Q2_USD":16530000.0,"OperatingLeaseExpense_2_Q2_USD":2600000.0,"OperatingLeaseExpense_1_Q2_USD":1400000.0,"OperatingIncomeLoss_2_Q2_USD":-28342000.0,"OperatingIncomeLoss_1_Q2_USD":-15237000.0,"OperatingExpenses_2_Q2_USD":28342000.0,"OperatingExpenses_1_Q2_USD":15237000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":12315000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":24910000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":10906000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":20496000.0,"VariableLeaseCost_2_Q2_USD":800000.0,"VariableLeaseCost_1_Q2_USD":400000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":26102278.0,"TemporaryEquitySharesIssued_0_Q2_shares":26102278.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":26102301.0,"TemporaryEquityLiquidationPreference_0_Q2_USD":247900000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":240735000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":31000.0,"StockholdersEquityNoteSubscriptionsReceivable_0_Q2_USD":12000.0,"StockholdersEquity_0_Q2_USD":-108536000.0,"ShortTermLeaseCost_2_Q2_USD":1200000.0,"ShortTermLeaseCost_1_Q2_USD":600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.006,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.008,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":1.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":1.03,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":1.03,"ShareBasedCompensation_2_Q2_USD":934000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":8558000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-111120000.0,"RestrictedCashNoncurrent_0_Q2_USD":547000.0,"NonoperatingIncomeExpense_2_Q2_USD":34000.0,"NonoperatingIncomeExpense_1_Q2_USD":27000.0,"NetIncomeLoss_2_Q2_USD":-28308000.0,"NetIncomeLoss_1_Q2_USD":-15210000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-13.26,"DepreciationDepletionAndAmortization_2_Q2_USD":1424000.0,"DepreciationAndAmortization_2_Q2_USD":1400000.0,"DepreciationAndAmortization_1_Q2_USD":700000.0,"CommonStockValue_0_Q2_USD":null,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":28925976.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-16650000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":112433000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":112433000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":111886000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1954000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":113222000.0,"Assets_0_Q2_USD":156895000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":28258310.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":934000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":502000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":502000.0,"AdditionalPaidInCapital_0_Q2_USD":2596000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":8124000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":664000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":3143000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-25.21,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":1147471.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":8400000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":7846000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-27808000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-7559000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":18717000.0,"LiabilitiesCurrent_0_Q2_USD":9800000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":156895000.0,"Liabilities_0_Q2_USD":24696000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":6907000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1603000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3792000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3910000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2445000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3678000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":23719000.0,"InvestmentIncomeInterest_2_Q2_USD":18000.0,"InvestmentIncomeInterest_1_Q2_USD":9000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-16000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":2954000.0,"IncreaseDecreaseInOperatingLeaseLiability_2_Q2_USD":-745000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1363000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-28308000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-15210000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4331000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":1122775.0,"Ticker":"TNYA","CIK":"1858848","name":"TENAYA THERAPEUTICS, INC.","OfficialName":"Tenaya Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"432348735.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210908"}]